Aug 13, 2020
Study: Medical Marijuana Associated with Fewer Hospitalizations for Individuals Living with Sickle Cell Disease
Aug 12, 2020
New Recommendations Aim to Increase Capacity for Specialized Care for Adults Living with Sickle Cell Disease
Jun 17, 2020
In Recognition of World Sickle Cell Day, The Sickle Cell Foundation of Tennessee Launches Feed Our Families Campaign, Webinar and Podcast
Jun 13, 2020
EHA25Virtual: Adult Patients With Sickle Cell Disease May Be at Increased Risk of Adverse Outcomes From COVID-19
Jun 01, 2020
Aruvant Appoints Dr. Palaniappan as Chief Technology Officer
May 11, 2020
Aruvant Appoints Joseph McIntosh, M.D. as Chief Medical Officer
Apr 16, 2020
2020 Harrington Prize Awarded to Dr. Stuart H. Orkin, Boston Children's Hospital
Mar 17, 2020
Sickle Cell Anemia Industry Outlook to 2026 Featuring CRISPR Therapeutics, Global Blood Therapeutics, Novartis, Pfizer, and Vertex Pharmaceuticals
Mar 10, 2020
/R E P E A T -- Media Advisory - Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!/
Jan 22, 2020
Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Dec 06, 2019
ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies
Nov 25, 2019
FDA approves novel treatment to target abnormality in sickle cell disease
Nov 25, 2019
California to Expand Innovative Adult Sickle Cell Disease Clinics Statewide
Nov 18, 2019
New Sickle Cell Drug With Oklahoma Roots Receives FDA Approval
Nov 15, 2019
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Nov 15, 2019
FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
Nov 14, 2019
Sickle Cell Disease (SCD) Epidemiology Forecast to 2028: Focus on Turkey, Saudi Arabia, UAE, Mexico, Colombia, Brazil, and Argentina
Nov 06, 2019
New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders
Nov 04, 2019
Sickle Cell Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Sep 26, 2019
Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26